A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

In 2016, veteran drug developer Suma Krishnan was in her early 50s when she began to seriously consider a radically different ...

Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), ...

Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, ...

Surging demand for vectors has also prompted suppliers to explore novel transfection technologies—including electroporation or transposon-based systems—to improve yield. Traditional methods rely on ...

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

Bionova Scientific announced the opening of a plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.